scholarly journals Surgically induced necrotizing scleritis after primary pterygium surgery with conjunctival autograft

2011 ◽  
pp. 1609 ◽  
Author(s):  
Katsuya Yamazoe ◽  
Seika Shimazaki-Den ◽  
Isao Otaka ◽  
Hotta ◽  
Shimazaki
Cornea ◽  
2008 ◽  
Vol 27 (6) ◽  
pp. 720-721 ◽  
Author(s):  
Vandana Jain ◽  
Debraj Shome ◽  
Sundaram Natarajan ◽  
Rohit Narverkar

Cornea ◽  
2008 ◽  
Vol 27 (6) ◽  
pp. 720-721 ◽  
Author(s):  
Vandana Jain ◽  
Debraj Shome ◽  
Sundaram Natarajan ◽  
Rohit Narverkar

Cornea ◽  
2002 ◽  
Vol 21 (3) ◽  
pp. 305-307 ◽  
Author(s):  
M. S. Sridhar ◽  
Aashish K. Bansal ◽  
Gullapalli N. Rao

2017 ◽  
Vol 8 (1) ◽  
pp. 195-199
Author(s):  
Pedro Coelho ◽  
Carlos Menezes ◽  
Pedro Rodrigues ◽  
Rita Gonçalves ◽  
Tiago Maio ◽  
...  

Purpose: To report a case of pterygium surgery with conjunctival autograft followed by focal necrotizing scleritis due to foreign body entrapment in the scleral bed. Case Report/Results: This is a case report of a 76-years-old male patient who underwent nasal pterygium surgery and developed focal necrotizing scleritis secondary to foreign body entrapment under conjunctival autograft. One month following surgery, slit-lamp examination demonstrated a progressive thinning of the surgical area with focal inflammatory signs. A small synthetic fiber was identified to be trapped under the graft. A second intervention was performed with foreign body removal and a new conjunctival graft. Despite the surgery, focal scleral melting continued to progress and the patient was placed under systemic corticotherapy and submitted to amniotic membrane graft with epithelial side up. During the follow-up period there was a good tissue response. Conclusion: Despite being a safe and quick procedure, pterygium surgery can sometimes elicit new challenges.


2020 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Ahmed Mostafa Ismail ◽  
Abd Allah Abdel Gawad ◽  
Riad Hassan

2021 ◽  
Vol 2 (3) ◽  
pp. 123-126
Author(s):  
Tian-Yu Wang ◽  
◽  
Min Yang ◽  
Yi Zhang ◽  
Zhao-Yang Wang ◽  
...  

AIM: To evaluate the safety and efficacy of limbal conjunctival autograft transplantation for treating primary pterygium over a period of 3y. METHODS: Prospective observational consecutive case series. In this study, 264 eyes of 264 patients (142 males and 122 females) with nasal primary pterygium were treated using the technique of limbal conjunctival autograft. The mean ages of the patients were 54.22±15.24y. After excision of the pterygium patients were followed up on 1, 3, 7d and at 1, 3, 6, 9, 12, and 36mo. Recurrence of pterygium, complications, operation time and corneal epithelialization time were evaluated. RESULTS: The average surgery time was 25.7±2.6min. With a minimum 3-year of follow-up, postoperative corneal epithelialization was completed in 3.85±0.72d. Complications were observed in 14 cases. Vision-threating complications such as iritis, scleral thinning symblepharon or ulceration were not detected in the study. Five eyes with graft edema, 3 eyes with granuloma formation and 6 cases with a subconjunctival hematoma in the nasal conjunctiva. By the end of 3-year follow-up, recurrence was detected in 11 cases. The recurrence rate was 4.17%, and the onset of recurrence was 3mo, the average recurrence time was 8mo. CONCLUSION: There were no severe complications and few recurrences when limbal conjunctival autograft transplantation was performed after long-term follow-up, we suggest that limbal conjunctival autograft transplantation is a safe and effective technique in primary pterygium. We also recommend that 12-month follow-up is optimal on primary pterygium surgery.


2017 ◽  
Vol 102 (6) ◽  
pp. 748-756 ◽  
Author(s):  
Ellen Carrara Fonseca ◽  
Eduardo Melani Rocha ◽  
Gustavo Viani Arruda

PurposePterygium is a frequent ocular disease, where the major challenge is the high level of recurrence after its surgical removal. We performed a network meta-analysis to identify, among several adjuvant treatments for primary pterygium, which is the best to prevent recurrence.MethodsA search was conducted using PubMed, Scientific Electronic Library Online, Latin American and Caribbean Centre on Health Sciences and Cochrane Eyes and Vision Group Trials Register between 1993 and 2015 for randomisedclinical trials (RCTs) comparing adjuvant treatments following primary pterygium surgery.Results24 RCTs that studied 1815 eyes of 1668 patients were included and allowed direct and indirect comparison among 14 interventions through network meta-analysis. The rank from the best to worse treatment to prevent recurrence is: conjunctival autograft + ciclosporin 0.05% eye drops, bare sclera + intraoperativemitomycin C (MMC) <0.02%, bare sclera + beta therapy (2500 cGy single dose), conjunctival autograft + beta therapy (1000 cGy single dose), bare sclera + MMC 0.02% eye drops, conjunctival autograft, bare sclera + intraoperative MMC >0.02%, bare sclera + ciclosporin 0.05% eye drops, bare sclera + intraoperative 5-fluorouracil 5%, amniotic membrane transplantation, bare sclera + intraoperative MMC 0.02%, conjunctival autograft + bevacizumab 0.05% eye drops, bare sclera + bevacizumab 0.05% eye drops and bare sclera alone.ConclusionThe best adjuvant treatment to prevent recurrence after primary pterygium surgery is the association of conjunctival autograft and ciclosporin 0.05% eye drops. Bare sclera technique alone should be discontinued since it is associated with high recurrence rates.


2017 ◽  
Vol 4 (6) ◽  
pp. 1866
Author(s):  
Satish D. Shet ◽  
Piyush S. Gupta

Background: Surgery is the treatment of choice in the management of primary pterygium. Recurrence following excision is frustrating to both the surgeons and patients alike. India being a tropical country is an ideal home for pterygium.Methods: This study was carried out in a tertiary care hospital. A comparative prospective study was performed in 80 patients presenting with primary pterygium who fulfill inclusion and exclusion criteria were taken for the study for the period from January 2011 to December 2012. They were randomised in two equal groups to undergo primary pterygium surgery with conjunctival autograft and excision of primary pterygium followed by intraoperative use of Mitomycin-C for 3 minutes to study the effectiveness of adjuncts i.e. mitomycin -C and conjunctival autograft in preventing recurrence of pterygium after excision and complications following the procedure. Follow up visits were scheduled for the postoperative days 1, 7, 30 days and 3 and 6 months. mean follow up was for 9 months.Results: No significant intra operative complications were noted except for 2 cases of button holing of the conjunctival graft. Recurrence was noted in 1 case after conjunctival autograft and 1 case in mitomycin C group.Conclusions: The adjuncts in primary pterygium surgery as conjunctival autograft and pterygium excision with mitomycin-C significantly reduces the recurrence rates than bare sclera excision alone.


Sign in / Sign up

Export Citation Format

Share Document